Join Now

Author Archives: Press Release

Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology, effective March 18, 2024. Dr. Daneker brings more than 30 years of oncology and precision medicine […]

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

Posted in BioUtah News | Tagged | Comments Off on bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

Posted in BioUtah News | Tagged | Comments Off on Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration

ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration

Posted in BioUtah News | Tagged | Comments Off on ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration

ARUP’s Julio Delgado, MD, MS, Selected as Inaugural Harry R. Hill, MD, Presidential Endowed Chair-Holder

ARUP’s Julio Delgado, MD, MS, Selected as Inaugural Harry R. Hill, MD, Presidential Endowed Chair-Holder

Posted in BioUtah News | Tagged | Comments Off on ARUP’s Julio Delgado, MD, MS, Selected as Inaugural Harry R. Hill, MD, Presidential Endowed Chair-Holder

Thermo Fisher Scientific Receives GMP approval from the Italian Medicines Agency (AIFA) for its Manufacturing facility of RNA-Based Products in Monza, Italy

GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients.

Posted in BioUtah News | Tagged | Comments Off on Thermo Fisher Scientific Receives GMP approval from the Italian Medicines Agency (AIFA) for its Manufacturing facility of RNA-Based Products in Monza, Italy

BD Helps Advance Health Equity for Women in Kenya through Critical Cancer Screening

Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates

Posted in BioUtah News | Tagged | Comments Off on BD Helps Advance Health Equity for Women in Kenya through Critical Cancer Screening

NUSANO NAMES ROHAN JAIN AS COMMERCIAL GENERAL MANAGER

Nusano Names Rohan Jain as Commercial General Manager.

Posted in BioUtah News | Tagged | Comments Off on NUSANO NAMES ROHAN JAIN AS COMMERCIAL GENERAL MANAGER

Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows

Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing

Posted in BioUtah News | Tagged | Comments Off on Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows

Update on kidneyIntelX.dkd Local Coverage Determination Consideration

Local Coverage Determination would result in contracted coverage for an estimated additional five million Medicare patients with Type 2 diabetes and early-stage chronic kidney disease

Posted in BioUtah News | Tagged | Comments Off on Update on kidneyIntelX.dkd Local Coverage Determination Consideration

First Patient Enrolled in Merit Medical’s MOTION Study

First Patient Enrolled in Merit Medical’s MOTION Study

Posted in BioUtah News | Tagged | Comments Off on First Patient Enrolled in Merit Medical’s MOTION Study

bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

Posted in BioUtah News | Tagged | Comments Off on bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance